CGN Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
CGN Advisors's LLY Position: Q2 2026 in Review
CGN Advisors increased its Eli Lilly (LLY) stake by 0.06% in Q2 2026, buying an estimated $2.04K and bringing the position to 3,311 shares worth $3.97M. The position accounts for 0.29% of the portfolio, ranked #66.
CGN Advisors first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- CGN Advisors held 3,311 shares of Eli Lilly worth $3.97M as of Q2 2026.
- CGN Advisors bought 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
- Eli Lilly made up 0.29% of CGN Advisors's portfolio in Q2 2026, its #66 holding.
- CGN Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
- 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on CGN Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.